[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Succeeding in the Europe HIV/AIDS Diagnostic Testing Market, 2019-2023: France, Germany, Italy, Spain, UK--Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities

June 2019 | 277 pages | ID: S880B83F202EN
Venture Planning Group

US$ 3,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

This 5-country report presents detailed analyses of the AIDS diagnostics market in Europe (France, Germany, Italy, Spain, UK). The report provides the 5-year test volume and sales forecasts by country for HIV-1/2/Combo, HIVAg/HIV NAT, HTLV-I/II, Western Blot and other confirmatory tests performed in the following markets:
  • Hospitals - Public Health Labs - Commercial/Private Labs
  • Blood Banks - Physician Offices - Ambulatory Care Centers
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.

Highlights

Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.

Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.

Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter/Danaher, bioMerieux, Ortho%li%Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.

Profiles leading manufacturers and potential market entrants developing innovative technologies and products.

Analyzes alternative market penetration strategies for suppliers.

Methodology

The report is based on a combination of primary and secondary information sources, including Venture Planning Group’s proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.

Contains 277 pages and 31 tables
I. INTRODUCTION

II. AIDS/HIV WORLDWIDE MARKET AND TECHNOLOGY OVERVIEW

A. Background
B. Diagnostic Tests: HIV-1/2/Combo , HIVAg/HIV NAT, Western Blot
C. Vaccines and Drugs
D. Instrumentation Review and Market Needs
E. Emerging Diagnostic Technologies

III. FRANCE: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

IV. GERMANY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

V. ITALY: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

VI. SPAIN: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

VII. UK: MARKET SIZE, GROWTH AND MAJOR SUPPLIERS' SALES AND MARKET SHARES

VIII. ALTERNATIVE MARKET PENETRATION STRATEGIES

A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
  1. Marketing Approaches
  2. Product Complexity
  3. Customer Preference
  4. Established Suppliers
  5. Emerging Suppliers
  6. Major Types of Distributors
  7. Market Segmentation

IX. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

X. COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Beckman Coulter/Danaher
Becton Dickinson
bioMerieux
Bio-Rad
Cepheid
Diamedix/Erba
DiaSorin
Eiken Chemical
Elitech Group
Enzo Biochem
Fujirebio
Grifols
Hologic/Gen-Probe
ID Biomedical/GSK
Kreatech/Leica
Lonza
Ortho-Clinical Diagnostics
Qiagen
Roche
Scienion
Sequenom
SeraCare
Siemens
Takara Bio
Thermo Fisher
Wallac/PE
Wako

LIST OF TABLES

Major Companies Developing or Marketing AIDS Tests
France: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts By Market Segment
France: HIV Ag Test Volume and Sales Forecasts By Market Segment
France: HIV NAT Blood Screening Test Volume and Diagnostics Sales
France: Western Blot/Other Confirmatory Tests Volume and Sales Forecasts by Market Segment
France: AIDS Diagnostics Market by Major Supplier
France: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Germany: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts By Market Segment
Germany: HIV Ag Test Volume and Sales Forecasts By Market Segment
Germany: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Germany: Western Blot/Other Confirmatory Tests Volume And Sales Forecasts by Market Segment
Germany: AIDS Diagnostics Market by Major Supplier
Germany: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Italy: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts By Market Segment
Italy: HIV Ag Test Volume and Sales Forecasts By Market Segment
Italy: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Italy: Western Blot/Other Confirmatory Tests Volume And Sales Forecasts by Market Segment
Italy: AIDS Diagnostics Market by Major Supplier
Italy: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
Spain: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts By Market Segment
Spain: HIV Ag Test Volume and Sales Forecasts By Market Segment
Spain: HIV NAT Blood Screening Test Volume and Diagnostics Sales
Spain: Western Blot/Other Confirmatory Tests Volume And Sales Forecasts by Market Segment
Spain: AIDS Diagnostics Market by Major Supplier
Spain: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers
UK: HIV or HIV-1/2/Combo Test Volume and Sales Forecasts By Market Segment
UK: HIV Ag Test Volume and Sales Forecasts By Market Segment
UK: HIV NAT Blood Screening Test Volume and Diagnostics Sales
UK: Western Blot/Other Confirmatory Tests Volume And Sales Forecasts by Market Segment
UK: AIDS Diagnostics Market by Major Supplier
UK: HIV Blood Screening NAT Sales and Market Shares of Major Suppliers


More Publications